Intracranial Pressure (ICP) Monitoring Market is further expected to expand at a CAGR of 4.9% over the forecast period of 2021-2031

News provided by

Persistence Market Research Pvt. Ltd.

Jan 27, 2022, 06:30 ET

NEW YORK, Jan. 27, 2022 /PRNewswire/ -- In a recent study done by Persistence Market Research, the global intracranial pressure (ICP) monitoring market recorded a market value of US$ 210.4 Mn in 2020. The market is further expected to expand at a CAGR of 4.9% over the forecast period of 2021-2031.

Intracranial pressure monitoring devices are used for the monitoring of increased level of intracranial pressure or the pressure of cerebrospinal fluid. Such devices are widely used in case of certain diseases such as subarachnoid hemorrhage, hydrocephalus, and malignant cerebral infarction (MCI) for providing proper treatment based on the testing.

There has been various technological advancements in recent times such as development of wireless ICP monitoring devices. Furthermore, innovation and approval for home-based ICP monitoring devices for patients suffering from hydrocephalus has been rising

For instance, the Raumed Home ICP device manufactured by Raumedic in 2019, also adds to the convenience of use of these products from the comfort of homes. The device allows the storing of certain activities on the handheld device, such as eating, sleeping, nausea, etc., with just the touch of a button. This provides better insights for therapy by neurosurgeons, which results in better treatment.

Request for sample copy of report: https://www.persistencemarketresearch.com/samples/5450

Key Takeaways from Market Study

Intracranial pressure monitoring devices used for measuring elevated intracranial pressure in the brain held more than 85% market share in 2020.
Intraventricular route of intervention held approximately 50% of the global market share in 2020.
Traumatic brain injury (TBI) is the most commonly seen indication for which ICP monitoring devices are used. TBI held a market share of around 37% in 2020.
Hospitals are preferred more by patients as they use a variety of techniques to monitor ICP- clinical examination, do brain imaging, and use ICP monitors, with overall easy reimbursement procedures. Hospitals accounted for nearly one-fourth of the global market share in 2020.
In 2020, North America dominated the ICP monitoring devices market, accounting for more than 55% of global market share.

Know the methodology of report: https://www.persistencemarketresearch.com/methodology/5450

"Increased cases of neurological diseases and advancements in diagnostics will propel demand for ICP monitoring devices over the coming years," says an analyst of Persistence Market Research.

Market Competition

Key manufacturers of ICP)monitoring devices are focusing on strategic partnerships with institutes and hospitals for the marketing of their products, getting approvals from various regulatory authorities globally, and expanding their portfolios for gaining market position.

In October 2021, IRRAS collaborated with Aarhus University Hospital in Aarhus, Denmark, one of the world's leading medical institutions. This collaboration helped in the business of IRRAflow.
Again, in December 2021, the company collaborated with the Lovell Government Services to sell IRRAflow and Hummingbird ICP product lines to Veterans Affairs (VA) hospitals and other U.S. government and military medical facilities.

Get full access of report: https://www.persistencemarketresearch.com/checkout/5450

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the intracranial pressure (ICP) monitoring market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.

The research study is based on product (ICP monitoring products and accessories), route of intervention (intraventricular, subdural, epidural, parenchymal, and subarachnoid), indication (traumatic brain injury, intracerebral haemorrhage, subarachnoid haemorrhage, hydrocephalus, malignant cerebral infarction (MCI), cerebral edema, CNS infections, and others), and end user (hospitals, ambulatory surgical centers, trauma centers, and neurosurgery centers), across seven key regions of the world.

Related Reports:

About Persistence Market Research:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

Overview:

Persistence Market Research is always way ahead of its time. In other words, it tables market solutions by stepping into the companies'/clients' shoes much before they themselves have a sneak pick into the market. The pro-active approach followed by experts at Persistence Market Research helps companies/clients lay their hands on techno-commercial insights beforehand, so that the subsequent course of action could be simplified on their part.

Contact

Rajendra Singh
Persistence Market Research
U.S. Sales Office:
305 Broadway, 7th Floor
New York City, NY 10007
+1-646-568-7751
United States
USA - Canada Toll-Free: 800-961-0353
Email: [email protected]

Visit Our Website: https://www.persistencemarketresearch.com

SOURCE Persistence Market Research Pvt. Ltd.